Search Results

There are 8342 results for: content related to: Depression and weight loss: opposite outcome for surgery and rimonabant?

  1. You have free access to this content
    Effects of Chronic Oral Rimonabant Administration on Energy Budgets of Diet-Induced Obese C57BL/6 Mice

    Obesity

    Volume 20, Issue 5, May 2012, Pages: 954–962, Li-Na Zhang, Yuko Gamo, Rachel Sinclair, Sharon E. Mitchell, David G. Morgan, John C. Clapham and John R. Speakman

    Version of Record online : 10 SEP 2012, DOI: 10.1038/oby.2011.357

  2. Cannabinoid type 1 receptor antagonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Kate Cahill and Michael H Ussher

    Published Online : 16 MAR 2011, DOI: 10.1002/14651858.CD005353.pub4

  3. Rimonabant for overweight or obesity

    Intervention Review

    The Cochrane Library

    Cintia Curioni and Charles André

    Published Online : 18 OCT 2006, DOI: 10.1002/14651858.CD006162.pub2

  4. You have free access to this content
    Effect of the Cannabinoid Receptor-1 Antagonist Rimonabant on Inflammation in Mice With Diet-Induced Obesity

    Obesity

    Volume 19, Issue 3, March 2011, Pages: 505–513, Qun Wang, Xiaoyuan D. Perrard, Jerry L. Perrard, Amir Mansoori, C. Wayne Smith, Christie M. Ballantyne and Huaizhu Wu

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2010.213

  5. Effect of antiobesity medications in patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 7, July 2009, Pages: 641–664, Souzana Choussein, Angeliki A. Makri, Constantinos C. Frangos, Eleni Th. Petridou and Stella S. Daskalopoulou

    Version of Record online : 18 FEB 2009, DOI: 10.1111/j.1463-1326.2008.01026.x

  6. You have free access to this content
    The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys

    British Journal of Pharmacology

    Volume 164, Issue 2b, September 2011, Pages: 655–666, Jennifer L Stewart and Lance R McMahon

    Version of Record online : 28 AUG 2011, DOI: 10.1111/j.1476-5381.2011.01388.x

  7. You have free access to this content
    Effects on Food Intake and Blood Lipids of Cannabinoid Receptor 1 Antagonist Treatment in Lean Rats

    Obesity

    Volume 16, Issue 11, November 2008, Pages: 2451–2455, Marianne F. Bennetzen, Maria P. Nielsen, Bjørn Richelsen and Steen B. Pedersen

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.390

  8. You have free access to this content
    The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy Expenditure

    Obesity

    Volume 17, Issue 2, February 2009, Pages: 254–261, Aaron N.A. Verty, Andrew M. Allen and Brian J. Oldfield

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.509

  9. You have free access to this content
    Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies

    Obesity

    Volume 19, Issue 7, July 2011, Pages: 1325–1334, Sara Jane Ward and Robert B. Raffa

    Version of Record online : 10 SEP 2012, DOI: 10.1038/oby.2011.69

  10. The Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome

    The Journal of Clinical Pharmacology

    Volume 47, Issue 5, May 2007, Pages: 642–652, Dr Anna I. Kakafika, Dr Dimitri P. Mikhailidis, Dr Asterios Karagiannis and Dr Vasilios G. Athyros

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007299358

  11. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 7, July 2010, Pages: 591–603, L. Zhang, N. J. Lee, A. D. Nguyen, R. F. Enriquez, S. J. Riepler, B. Stehrer, E. Yulyaningsih, S. Lin, Y. C. Shi, P. A. Baldock, H. Herzog and A. Sainsbury

    Version of Record online : 21 DEC 2009, DOI: 10.1111/j.1463-1326.2009.01193.x

  12. You have free access to this content
    The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism – or inverse agonism – as potential obesity treatment and other therapeutic use

    Journal of Clinical Pharmacy and Therapeutics

    Volume 32, Issue 3, June 2007, Pages: 209–231, S. Xie, M. A. Furjanic, J. J. Ferrara, N. R. McAndrew, E. L. Ardino, A. Ngondara, Y. Bernstein, K. J. Thomas, E. Kim, J. M. Walker, S. Nagar, S. J. Ward and R. B. Raffa

    Version of Record online : 2 MAY 2007, DOI: 10.1111/j.1365-2710.2007.00817.x

  13. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 2, February 2010, Pages: 158–166, N. Perwitz, J. Wenzel, I. Wagner, J. Büning, M. Drenckhan, K. Zarse, M. Ristow, W. Lilienthal, H. Lehnert and J. Klein

    Version of Record online : 5 NOV 2009, DOI: 10.1111/j.1463-1326.2009.01133.x

  14. Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies

    Addiction Biology

    Volume 13, Issue 2, June 2008, Pages: 239–252, Bernard Le Foll, Benoit Forget, Henri-Jean Aubin and Steven R. Goldberg

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1369-1600.2008.00113.x

  15. You have free access to this content
    The Central Cannabinoid CB1 Receptor Is Required for Diet-Induced Obesity and Rimonabant's Antiobesity Effects in Mice

    Obesity

    Volume 19, Issue 10, October 2011, Pages: 1923–1934, Zhen Pang, Nancy N. Wu, Weiguang Zhao, David C. Chain, Erica Schaffer, Xin Zhang, Preeti Yamdagni, Vaseem A. Palejwala, Chunpeng Fan, Sarah G. Favara, Holly M. Dressler, Kyriakos D. Economides, Daniel Weinstock, Jean S. Cavallo, Souad Naimi, Anne-Marie Galzin, Etienne Guillot, Marie-Pierre Pruniaux, Michael J. Tocci and H. Greg Polites

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2011.250

  16. You have free access to this content
    Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon

    International Journal of Cancer

    Volume 125, Issue 5, 1 September 2009, Pages: 996–1003, Antonietta Santoro, Simona Pisanti, Claudia Grimaldi, Angelo A. Izzo, Francesca Borrelli, Maria C. Proto, Anna M. Malfitano, Patrizia Gazzerro, Chiara Laezza and Maurizio Bifulco

    Version of Record online : 6 APR 2009, DOI: 10.1002/ijc.24483

  17. You have free access to this content
    Blockade of the Endocannabinoid System for the Reduction of Cardiometabolic Risk Factors

    Obesity

    Volume 17, Issue 2, February 2009, Pages: 220–225, Frederick F. Samaha and Carol M. Chou

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.476

  18. Long-term pharmacotherapy for obesity and overweight

    Intervention Review

    The Cochrane Library

    Raj S Padwal, Diana Rucker, Stephanie K Li, Cintia Curioni and David CW Lau

    Published Online : 20 OCT 2003, DOI: 10.1002/14651858.CD004094.pub2

  19. You have free access to this content
    Endocannabinoid control of gastric sensorimotor function in man

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 10, May 2010, Pages: 1123–1131, K. AMELOOT, P. JANSSEN, E. SCARPELLINI, R. VOS, W. BOESMANS, I. DEPOORTERE, P. VANDEN BERGHE and J. TACK

    Version of Record online : 8 FEB 2010, DOI: 10.1111/j.1365-2036.2010.04259.x

  20. You have free access to this content
    The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction

    Addiction Biology

    Volume 13, Issue 2, June 2008, Pages: 160–187, José Antonio López-Moreno, Gustavo González-Cuevas, Guillermo Moreno and Miguel Navarro

    Version of Record online : 16 APR 2008, DOI: 10.1111/j.1369-1600.2008.00105.x